Clinical Trial: Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

Clinical Trial: Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

Sponsor and Collaborators
AIDS Malignancy Clinical Trials Consortium
National Cancer Institute (NCI)

Principal Investigator
Study Chair: Erin G. Reid, MD University of California, San Diego
Principal Investigator: William Wachsman, MD University of California, San Diego

ClinicalTrials.gov Identifier
NCT00598169